Scientists at the Dana-Farber Cancer Institute have made what can be considered a breakthrough in advanced kidney cancer treatment.
According to the American Cancer Society, kidney cancer is among the 10 most common cancers in the country. For women, the lifetime risk of developing kidney cancer is 1 in 83, and for men 1 in 58. According to the organization’s estimates, more than 70,000 new kidney cancer cases will occur in 2019, and nearly 15,000 people will die from this disease within a year.
Although the death rates for kidney cancers have gone down since the middle of the 1990s, the rate of new kidney cancers has been rising, which is part of the reason why research by the Dana-Farber Cancer Institute, published in the New England Journal of Medicine, can be considered significant.
0 comments :
Post a Comment